-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
Titan Pharmaceuticals Inc quarterly/annual Net Cash Provided by (Used in) Operating Activities history and growth rate from Q1 2011 to Q1 2024.
- Titan Pharmaceuticals Inc Net Cash Provided by (Used in) Operating Activities for the quarter ending March 31, 2024 was -$613K, a 67.7% increase year-over-year.
- Titan Pharmaceuticals Inc annual Net Cash Provided by (Used in) Operating Activities for 2023 was -$7.09M, a 13.3% increase from 2022.
- Titan Pharmaceuticals Inc annual Net Cash Provided by (Used in) Operating Activities for 2022 was -$8.18M, a 3.6% decline from 2021.
- Titan Pharmaceuticals Inc annual Net Cash Provided by (Used in) Operating Activities for 2021 was -$7.9M, a 54.1% increase from 2020.
Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Growth (%)